Presentation is loading. Please wait.

Presentation is loading. Please wait.

Mechanism of action for pulmonary arterial hypertension medications.

Similar presentations


Presentation on theme: "Mechanism of action for pulmonary arterial hypertension medications."— Presentation transcript:

1 Mechanism of action for pulmonary arterial hypertension medications.
Mechanism of action for pulmonary arterial hypertension medications. Solid black arrows indicate that the compound stimulates its target, facilitates a reaction or induces a change in vascular tone. Dotted white arrows indicate that the compound inhibits its target. AC, adenylyl cyclase; ATP, adenosine triphosphate; cAMP, cyclic adenosine monophosphate; cGMP, cyclic guanosine monophosphate; GMP, guanosine monophosphate; GTP, guanosine triphosphate; IP, prostaglandin I2 receptor; NO, nitric oxide; PDE-5, phosphodiesterase-5; PGI2, prostaglandin I2; sGC, soluble guanylyl cyclase. Daniel L Varela et al. Open Heart 2018;5:e000744 ©2018 by British Cardiovascular Society


Download ppt "Mechanism of action for pulmonary arterial hypertension medications."

Similar presentations


Ads by Google